Literature DB >> 15655706

Physiology of GLP-1--lessons from glucoincretin receptor knockout mice.

B Thorens1.   

Abstract

GLP-1 has both peripheral and central actions, as this hormone is secreted by gut endocrine cells and brainstem neurons projecting into the hypothalamus and other brain regions. GLP-1 has multiple regulatory functions participating in the control of glucose homeostasis, beta-cell proliferation and differentiation, food intake, heart rate and even learning. GLP-1 action depends on binding to a specific G-coupled receptor linked to activation of the adenylyl cyclase pathway. Analysis of mice with inactivation of the GLP-1 receptor gene has provided evidence that absence of GLP-1 action in the mouse, despite this hormone potent physiological effects when administered in vivo, only leads to mild abnormalities in glucose homeostasis without any change in body weight. However, a critical role for this hormone and its receptor was demonstrated in the function of the hepatoportal vein glucose sensor, in contrast to that of the pancreatic beta-cells, although absence of both GLP-1 and GIP receptors leads to a more severe phenotype characterized by a beta-cell-autonomous defect in glucose-stimulated insulin secretion. Together, the studies of these glucoincretin receptor knockout mice provide evidence that these hormones are part of complex regulatory systems where multiple redundant signals are involved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15655706     DOI: 10.1055/s-2004-826161

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

Review 1.  Intestinal GLP-1 and satiation: from man to rodents and back.

Authors:  R E Steinert; C Beglinger; W Langhans
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

2.  Sleeve Gastrectomy Improves High-Fat Diet-Associated Hepatic Steatosis Independent of the Glucagon-like-Petpide-1 Receptor in Rats.

Authors:  Matthew Barron; Hailey Hayes; Deemantha G Fernando; Aron M Geurts; Tammy L Kindel
Journal:  J Gastrointest Surg       Date:  2022-05-26       Impact factor: 3.267

3.  Nogo-A downregulation improves insulin secretion in mice.

Authors:  Claire B Bonal; Delphine E Baronnier; Caroline Pot; Mahdia Benkhoucha; Martin E Schwab; Patrice H Lalive; Pedro L Herrera
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

4.  COUP-TFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathways.

Authors:  Marie Boutant; Oscar Henrique Pereira Ramos; Cécile Tourrel-Cuzin; Jamileh Movassat; Anissa Ilias; David Vallois; Julien Planchais; Jean-Paul Pégorier; Frans Schuit; Patrice X Petit; Pascale Bossard; Kathrin Maedler; Anne Grapin-Botton; Mireille Vasseur-Cognet
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.